menu
    • menu

    Company profile for Bio-Thera Solutions

    NEW Drugs in Dev: 38
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bio-Thera Solutions is a clinical-stage pharmaceutical company focused on biologic therapeutics. Bio-Thera is developing a pipeline on innovative enhanced monoclonal antibodies and antibody-drug conjugates for the treatment of a broad range of cancers and other diseases as well as a pipeline of biosimilars in the autoimmune and oncology therapeutic areas. The company is headquartered in Guangzhou, China.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bio-Thera SolutionsChina Flag
    Country
    Country
    China
    Address
    Address
    Bldg A6-5fl, 11Kai-Yuan Blvd, Science City, Guangzhou
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bio-thera.com/EN/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bio-thera-solutions-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bio-Thera Golimumab Biosimilars Gain First FDA Approval
    Bio-Thera Golimumab Biosimilars Gain First FDA Approval

    18 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-thera-solutions-golimumab-biosimilars-receive-fda-approval-as-first-biosimilars-to-simponi-and-simponi-aria-accord-biopharma-to-commercialize-immgolis-golimumab-sldi-and-immgolis-intri-golimumab-sldi-in-the-united-st-302774570.html

    PR NEWSWIRE
    18 May 2026
    Share Share
    Bio-Thera Expands Intas Pharma Partnership for BAT2506
    Bio-Thera Expands Intas Pharma Partnership for BAT2506

    23 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-thera-solutions-announces-further-expansion-of-partnership-with-intas-pharmaceuticals-for-bat2506-a-proposed-biosimilar-referencing-simponi-golimumab-through-exclusive-commercialization-and-license-agreement-in-india-302721985.html

    PR NEWSWIRE
    23 Mar 2026
    Share Share
    STADA and Bio-Thera Secure EU Approval for Gotenfia
    STADA and Bio-Thera Secure EU Approval for Gotenfia

    13 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/stada-and-bio-thera-receive-european-marketing-authorization-for-gotenfia-a-biosimilar-to-simponi-302687571.html

    PR NEWSWIRE
    13 Feb 2026
    Share Share
    STADA & Bio-Thera's Gotenfia Biosimilar Get Positive CHMP Opinion
    STADA & Bio-Thera's Gotenfia Biosimilar Get Positive CHMP Opinion

    12 Dec 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/golimumab-biosimilar-gotenfia-from-stada-and-bio-thera-receives-positive-chmp-opinion-302640091.html

    PR NEWSWIRE BIO
    12 Dec 2025
    Share Share
    Bio-Thera Announces Expansion of Partnership with Intas Pharma
    Bio-Thera Announces Expansion of Partnership with Intas Pharma

    09 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-thera-solutions-announces-expansion-of-partnership-with-intas-pharmaceuticals-for-bat2506-a-proposed-biosimilar-referencing-simponi-golimumab-through-exclusive-commercialization-and-license-agreement-in-canada-302579683.html

    PR NEWSWIRE
    09 Oct 2025
    Share Share
    Bio-Thera's Biosimilar Referencing Stelara Approved in the EU
    Bio-Thera's Biosimilar Referencing Stelara Approved in the EU

    26 Aug 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/bio-theras-biosimilar-referencing-stelara-approved-in-the-eu/

    CONTRACTPHARMA
    26 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search